We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkers.
- Authors
Tan, E-H; Goh, C; Lim, W T; Soo, K C; Khoo, M L; Tan, T; Tan, D S W; Ang, M K; Ng, Q S; Tan, P H; Lim, A; Hwang, J; Teng, Y H F; Lim, T H; Tan, S H; Baskaran, N; Hui, K M
- Abstract
Gefitinib was demonstrated to be synergistic with cisplatin and radiotherapy (RT) in in vitro studies. Biomarkers predictive of response to gefitinib in squamous cell head and neck cancer is still lacking.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Vol 23, Issue 4, p1010
- ISSN
1569-8041
- Publication type
Journal Article
- DOI
10.1093/annonc/mdr327